Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

2 ArticlesSPARC

1 / 1

Sun Pharma Advanced Research inks deal with Sun Pharmaceutical Industries for Epilepsy Drug

As per the press release the agreement is for Levetiracetam extended release tablet, ELEPSIA XR. This drug was approved by the US FDA in March, 2015 but was ...
Sun-Pharma-Share-Price-18-July-2016.png

Seafarer Capital Partners enter Cyient with 936,637 shares representing 0.83%

  Cyient a company focusses on engineering, networks and operations. The company features among the top 30 outsourcing companies in the world. The ...
cyient-logo.png